Advocacy for outpatient cardiac rehabilitation globally

[1]  S. Grace,et al.  Narrative review comparing the benefits of and participation in cardiac rehabilitation in high-, middle- and low-income countries. , 2015, Heart, lung & circulation.

[2]  Cate Ferry,et al.  Australian Cardiovascular Health and Rehabilitation Association (ACRA) core components of cardiovascular disease secondary prevention and cardiac rehabilitation 2014. , 2015, Heart, lung & circulation.

[3]  R. Taylor,et al.  Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. , 2014, International journal of cardiology.

[4]  F. Lopez‐Jimenez,et al.  Cardiac rehabilitation in Latin America. , 2014, Progress in cardiovascular diseases.

[5]  R. Squires,et al.  Commercial Insurance Coverage for Outpatient Cardiac Rehabilitation in Patients With Heart Failure in the United States , 2014, Journal of cardiopulmonary rehabilitation and prevention.

[6]  N. Sarrafzadegan,et al.  Global availability of cardiac rehabilitation , 2014, Nature Reviews Cardiology.

[7]  R. Sacco,et al.  Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease Taskforce , 2014, Journal of the American Heart Association.

[8]  J. Killian,et al.  Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction. , 2014, The American journal of medicine.

[9]  K. Kotseva,et al.  Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey , 2013, European journal of preventive cardiology.

[10]  C. Held,et al.  Physical activity in patients with stable coronary heart disease: an international perspective , 2013, European heart journal.

[11]  J. Buckley,et al.  International Charter on Cardiovascular Prevention and Rehabilitation: a call for action. , 2013, Journal of cardiopulmonary rehabilitation and prevention.

[12]  P. Doherty,et al.  BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation , 2013, Heart.

[13]  Tim Smith,et al.  The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. , 2013, European heart journal.

[14]  F. Lopez‐Jimenez,et al.  Availability and Characteristics of Cardiovascular Rehabilitation Programs in South America , 2013, Journal of Cardiopulmonary Rehabilitation and Prevention.

[15]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[16]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[17]  F. Lalonde,et al.  Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs , 2012 .

[18]  L. Annemans,et al.  An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy , 2012, European journal of preventive cardiology.

[19]  N. Oldridge.  Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited. , 2012, Future cardiology.

[20]  W. Wong,et al.  A systematic review of economic evaluations of cardiac rehabilitation , 2012, BMC Health Services Research.

[21]  Bernard Pierre,et al.  French Society of Cardiology guidelines for cardiac rehabilitation in adults. , 2012, Archives of cardiovascular diseases.

[22]  S. Mendis,et al.  Social and Economic Implications of Noncommunicable diseases in India , 2011, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.

[23]  H. McGee,et al.  Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  S. Normand,et al.  Cardiac rehabilitation and survival in older coronary patients. , 2009, Journal of the American College of Cardiology.

[25]  M. Piepoli,et al.  The Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (IACPR-GICR). , 2008, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[26]  D. Stewart,et al.  Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[27]  Ron Goeree,et al.  Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients , 2008, Circulation. Cardiovascular quality and outcomes.

[28]  J. Berger,et al.  Long-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary intervention , 2008, Acta cardiologica.

[29]  Taghreed Adam,et al.  The burden and costs of chronic diseases in low-income and middle-income countries , 2007, The Lancet.

[30]  Sharon-Lise T Normand,et al.  Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery , 2007, Circulation.

[31]  E. Finkelstein,et al.  The Economic Burden of Chronic Cardiovascular Disease for Major Insurers , 2007, Health promotion practice.

[32]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Circulation.

[33]  R. Hayward,et al.  Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease , 2007, Circulation.

[34]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Journal of cardiopulmonary rehabilitation and prevention.

[35]  Alastair Gray,et al.  Economic burden of cardiovascular diseases in the enlarged European Union. , 2006, European heart journal.

[36]  D. Curnier,et al.  Geographic distribution of cardiac rehabilitation programs in the United States. , 2005, Journal of cardiopulmonary rehabilitation.

[37]  I. Piña,et al.  Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. , 2000, Circulation.

[38]  F. Pashkow,et al.  Cost-effectiveness of cardiac rehabilitation after myocardial infarction. , 1996, Journal of cardiopulmonary rehabilitation.

[39]  J. Cleland,et al.  Is medical treatment for angina the most cost-effective option? , 1997, European heart journal.

[40]  M. Johannesson,et al.  Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. , 1997, The New England journal of medicine.

[41]  L. Levin,et al.  Cardiac rehabilitation — a cost analysis , 1991, Journal of internal medicine.

[42]  N. Pogosova,et al.  [Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery]. , 2014, Kardiologiia.

[43]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[44]  T. Gaziano.  Reducing the growing burden of cardiovascular disease in the developing world. , 2007, Health affairs.

[45]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. , 2007, The Journal of cardiovascular nursing.

[46]  H. Hämäläinen,et al.  Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. , 1997, Journal of cardiopulmonary rehabilitation.

[47]  J. Zhang,et al.  Economic burden of illness in Canada, 1993. Executive summary and recommendations. , 1997, Chronic diseases in Canada.

[48]  Frank A. Sloan,et al.  Valuing health care : costs, benefits, and effectiveness of pharmaceuticals and other medical technologies , 1995 .

[49]  Leo Smith,et al.  American Association of Cardiovascular and Pulmonary Rehabilitation , 1986 .